Techcyte works with Aignostics to Preview Tissue Microarray Workflow Connecting Fusion AP to TMA Grand Master by Epredia

OREM, UT, UNITED STATES, October 15, 2026 /EINPresswire.com/ -- Techcyte, developer of Fusion, the enterprise digital ...
Microbiologia Italia on MSN

Cercare il gene che rivela la resistenza

Scopri come cercare il gene che rivela la resistenza agli antibiotici con tecniche molecolari e strumenti innovativi. Questo ...

DNA・遺伝子チップ市場、2025年の92億ドルから2030年には169.9億ドルへほぼ倍増

5年でほぼ倍増する市場は、そう多くありません。DNA・遺伝子チップ市場は、2025年の92億ドルから2030年には169.9億ドルへ、成長率12.9%で拡大する見通しです。その原動力は、がんを早期に見つけたいという、ごく人間的な目標です。
Nature

Molecular ecology articles from across Nature Portfolio

An article in Molecular Ecology describes the factors shaping microbial eukaryotic populations and their role in the carbon cycle at deep-sea hydrothermal vents.
BIOENGINEER

White Shark Algorithm Shows Promise for Classifying High-Dimensional Cancer Data

Researchers adapted a swarm intelligence algorithm modeled on great white shark hunting behavior to select the most informative genes from high-dimensional microarray cancer datasets, achieving top ...

Gene Expression Market Size, Share, Trends, Growth, and Forecast 2026-2035 | AI-Driven Genomics Unlocks 10.40% CAGR and a USD 39.48 Billion Global Opportunity

Precision medicine, RNA sequencing, single-cell analysis and AI-driven genomics fuel adoption, while recurring consumables demand and North American leadership shape opportunitiesDublin, Oct. 07, 2026 ...
BIOENGINEER

DNA Methylation Episignatures Emerge as a Powerful New Diagnostic Layer for Rare Disease

A new review explains how DNA methylation episignatures provide functional evidence of disease mechanism in rare genetic ...

EQS-News: EpiSign and Geneyx Announce Partnership to Integrate Genomic and Epigenomic Analysis for Rare Disease

LONDON, ON and HERZLIYA, Israel, Oct. 5, 2026 /PRNewswire/ -- EpiSignInc. and GeneyxGenomex Ltd. today announced a partnership to advance the integration of genomic and epigenomic analysis for ...
PR Newswire

EpiSign and Geneyx Announce Partnership to Integrate Genomic and Epigenomic Analysis for Rare Disease

EpiSign Inc. and Geneyx Genomex Ltd. today announced a partnership to advance the integration of genomic and epigenomic analysis ...

Global Oligonucleotide Synthesis Reagents Market Size, Share, and Forecast, 2026-2033 | Therapeutics Demand Fuels 11.9% CAGR and USD 1.75 Billion Opportunity

Capitalize on demand for nucleic acid therapeutics, diagnostics and genomics with insights into high-potential segments, regional opportunities and competitive strategies.Dublin, Oct. 05, 2026 (GLOBE ...
PR Newswire

EpiSign Launches METRIC 5-base, Enabling Comprehensive Episignature Analysis Across Genome-Sequencing Platforms

EpiSign Inc. today announced the launch of EpiSign METRIC 5-base, extending its comprehensive and automated episignature analysis ...

Global Drug Discovery Market Forecast 2026-2032: AI, Precision Biology, Multi-Omics, and Advanced Modalities are Reshaping Discovery Workflows

Opportunities span AI-enabled discovery, multi-omics, precision medicine, advanced therapies, biomarker-led trials, data platforms, CRO partnerships and Asia-Pacific expansionDublin, Sept. 22, 2026 ...